日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular impact of NOTCH signaling dysregulation on ovarian cancer progression, chemoresistance, and taxane response

NOTCH信号通路失调对卵巢癌进展、化疗耐药性和紫杉烷类药物反应的分子影响

Koucka, Kamila; Spalenkova, Alzbeta; Seborova, Karolina; Tesarova, Tereza; Ehrlichova, Marie; Krus, Ivona; Holy, Petr; Rob, Lukas; Hruda, Martin; Bouda, Jiri; Bartakova, Alena; Smoligova, Vendula; Ojima, Iwao; Chen, Lei; Bendale, Hersch; Mrhalova, Marcela; Kopeckova, Katerina; Soucek, Pavel; Vaclavikova, Radka

Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma

端粒长度作为卵巢癌患者治疗反应和生存的预测指标

Kristyna Tomasova, Karolina Seborova, Michal Kroupa, Josef Horak, Miriam Kavec, Ludmila Vodickova, Lukas Rob, Martin Hruda, Marcela Mrhalova, Alena Bartakova, Jiri Bouda, Thomas Fleischer, Vessela N Kristensen, Pavel Vodicka, Radka Vaclavikova

Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy

上皮性卵巢癌患者DNA修复基因的复杂分子谱与对铂类药物治疗的敏感性呈正相关

Seborova, Karolina; Hlavac, Viktor; Holy, Petr; Bjørklund, Sunniva S; Fleischer, Thomas; Rob, Lukas; Hruda, Martin; Bouda, Jiri; Mrhalova, Marcela; Allah, Mohammad Moufaq Khatar Al Obeed; Vodicka, Pavel; Fiala, Ondrej; Soucek, Pavel; Kristensen, Vessela N; Vodickova, Ludmila; Vaclavikova, Radka

The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes

TRIP6、ABCC3和CPS1表达在卵巢癌对紫杉烷类药物耐药中的作用

Karolina Seborova, Alzbeta Kloudova-Spalenkova, Kamila Koucka, Petr Holy, Marie Ehrlichova, Changwei Wang, Iwao Ojima, Iveta Voleska, Petr Daniel, Kamila Balusikova, Michael Jelinek, Jan Kovar, Lukas Rob, Martin Hruda, Marcela Mrhalova, Pavel Soucek, Radka Vaclavikova

A modified approach for I-FISH evaluation of ERBB2 (HER-2) gene copy numbers in breast carcinomas: comparison with HER-2/CEP17 ratio system

一种改进的I-FISH方法用于评估乳腺癌中ERBB2(HER-2)基因拷贝数:与HER-2/CEP17比值系统的比较

Mrhalova, Marcela; Kodet, Roman